Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

RhoA helps skin stem cells grow, aiding wound healing.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Activating Tgr5 may help treat hair loss and bone loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Mutations in the hairless protein gene cause hair loss.

Scientists found 53 keratin genes in yaks that are important for hair growth and share similarities with those in other animals.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.